What changed: Anal cancer (squamous cell carcinoma)
Every dated change on the records linked to Anal cancer (squamous cell carcinoma), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
September 2026 · 1
2025 · 1
2024 · 1
2022 · 2
- 2022GuidelineAnal cancer (squamous cell carcinoma)Guideline ANCHOR (NEJM 2022): Precancer (HSIL) in people with HIV
Screening with anal cytology / high-resolution anoscopy and treatment of HSIL (ablation, topical therapy) reduces progression to cancer by 57% (ANCHOR).
- 2022MilestoneThermal ablation and cryotherapy for cervical precancerANCHOR: treating HSIL prevents anal cancer in people with HIV
A milestone in how this cancer is treated.
2020 · 1
2017 · 1
2013 · 2
2006 · 2
- 2006ApprovalHPV quadrivalent vaccine (types 6, 11, 16 and 18)HPV quadrivalent vaccine (types 6, 11, 16 and 18) approved in EU
Prevention of premalignant genital lesions, cervical cancer and genital warts from age 9 (Gardasil); anal lesions and cancer added later
- 2006ApprovalHPV quadrivalent vaccine (types 6, 11, 16 and 18)HPV quadrivalent vaccine (types 6, 11, 16 and 18) approved in US
Prevention of cervical, vulvar and vaginal cancers and precancers and genital warts caused by HPV 6, 11, 16 and 18 in females 9 to 26 (males 2009; anal cancer 2010); superseded by Gardasil 9